Vibrating capsule shows promising results in treating chronic constipation

May 3, 2014

An oral capsule that vibrates as it moves through the digestive tract has shown notable promise as a non-pharmacological treatment for constipation, according to new research presented today at Digestive Disease Week (DDW). In the pilot study, the vibrating capsule was found to nearly double the weekly bowel movements of patients suffering from chronic idiopathic constipation (CIC) and constipation predominant irritable bowel syndrome (C-IBS).

"Despite the widespread use of medication to treat , nearly 50 percent of patients are unsatisfied with the treatment either because of , safety concerns about long-term use, or the fact that it simply doesn't work," said Yishai Ron, MD, lead researcher for the study and director of Neurogastroenterology and Motility at Tel-Aviv Sourasky Medical Center's Department of Gastroenterology and Hepatology.

Twenty-six patients took the vibrating capsule twice per week and responded to a daily and laxative use questionnaire. All patients initially underwent a two-week preliminary period without the use of laxatives. Patients reported an increase in spontaneous bowel movements from two to four times per week, as well as a decrease in constipation symptoms, including reduced difficulty in passing stools and incomplete evacuation. The study also found minimal side effects from the capsule use.

The capsule, which houses a small engine inside, is programmed to begin vibrating six to eight hours after swallowing. The vibrations (mechanical stimulations) cause contractions in the intestine, which help move stool through the .

Chronic constipation is a highly prevalent disorder that affects approximately 15 percent of the U.S. population. Symptoms can be burdensome, leading to a reduction in patients' quality of life.

"Sometimes, drug therapies bring more issues than relief for these patients," Dr. Ron said. "The results of this study point to the potential for an alternative treatment that avoids the typical drug side effects, such as bloating and electrolyte imbalance, by imitating the body's natural physiology."

Dr. Ron said he and his team plan to initiate a controlled, double blind study to expand on these findings and further explore the capsule's potential.

Dr. Ron will present data from the study "Vibrating Capsule for the Treatment of Chronic Idiopathic Constipation (CIC) and Constipation Predominant Irritable Bowel Syndrome (C-IBS) – Safety and Efficacy," abstract Sa2023, on Saturday, May 3, at 8:30 a.m. CT in the South Hall of McCormick Place.

Related Stories

Researchers find new treatment for constipation

May 10, 2011

Constipation is definitely not a glamorous topic. In reality, it affects nearly 30 million Americans and costs more than $1 billion annually to evaluate and treat. While not often life threatening, the pain, bloating, discomfort, ...

New drug approved for irritable bowel, chronic constipation

August 30, 2012

(HealthDay)—Linzess (linaclotide) has been approved by the U.S. Food and Drug Administration to treat forms of chronic constipation that don't respond to traditional treatment, and irritable bowel syndrome accompanied by ...

New drug to help common bowel disease

October 29, 2013

(Medical Xpress)—An international team led by University of Adelaide researchers has identified the mechanism of pain relief of a new drug for treating Irritable Bowel Syndrome with Constipation (IBS-C), based on nonclinical ...

Researchers find genetic clue to irritable bowel syndrome

March 20, 2014

Is irritable bowel syndrome (IBS) caused by genetics, diet, past trauma, anxiety? All are thought to play a role, but now, for the first time, researchers have reported a defined genetic defect that causes a subset of IBS. ...

Bowel illnesses sometimes coincide in kids

April 21, 2014

(HealthDay)—Children suffering from irritable bowel syndrome are four times more likely than other kids to have a condition called celiac disease—an allergy to gluten—Italian researchers report.

Recommended for you

Experimental MERS vaccine shows promise in animal studies

July 28, 2015

A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines. ...

Can social isolation fuel epidemics?

July 21, 2015

Conventional wisdom has it that the more people stay within their own social groups and avoid others, the less likely it is small disease outbreaks turn into full-blown epidemics. But the conventional wisdom is wrong, according ...

Lack of knowledge on animal disease leaves humans at risk

July 20, 2015

Researchers from the University of Sydney have painted the most detailed picture to date of major infectious diseases shared between wildlife and livestock, and found a huge gap in knowledge about diseases which could spread ...

IBD genetically similar in Europeans and non-Europeans

July 20, 2015

The first genetic study of inflammatory bowel disease (IBD) to include individuals from diverse populations has shown that the regions of the genome underlying the disease are consistent around the world. This study, conducted ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.